Pediatrix Medical Group, Inc. MD

Healthcare SIC 8060 - Services-Hospitals NYSE

Pediatrix is a leading provider of physician services including newborn, maternal-fetal, and other pediatric subspecialty care. Our national network is comprised of affiliated physicians who provide clinical care in 37 states. During 2024, we formalized our practice portfolio management plans, resulting in a decision to exit almost all of our affiliated office-based practices, other than maternal-fetal medicine. As of December 31, 2024, these plans were completed. Additionally, we exited our primary and urgent care service line during 2024 based on a review of the cost and time that would be required to build the platform to scale. At December 31, 2025, our national network comprised approximately 2,295 affiliated physicians, including 1,350 physicians who provide neonatal clinical care, primarily within hospital-based neonatal intensive care units ("NICUs"), to babies born prematurely or with medical complications. We have over 475 affiliated physicians who provide maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where our affiliated neonatal physicians practice. Our network also includes other pediatric subspecialists, including over 230 physicians providing pediatric intensive care, 220 physicians providing hospital-based pediatric care, and 20 physicians providing pediatric surgical care.

Last close 27.03 2026-09-04
Market cap $2.20B 2026-06-30 share count
52-week range 15.70 - 27.94

Valuation FY2025 figures against the last close

P/S1.1x
P/E13.9x
P/FCF8.1x
EV/EBITDA9.5x
Dividend yield
Diluted EPS1.94

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $1.91B$2.01B$1.99B$1.97B$1.91B$1.73B$1.78B$1.72B$3.25B$3.18B
SG&A $240.8M$238.4M$227.5M$231.4M$263.4M$248.9M$244.5M$232.2M$385.9M$372.6M
Total operating expenses $1.71B$2.08B$1.99B$1.80B$1.71B$1.64B$1.61B$1.47B$2.80B$2.61B
Operating income $208.8M-$68.7M$7.3M$172.7M$202.9M$98.1M$171.8M$248.4M$454.9M$571.7M
Interest expense $36.0M$40.7M$42.1M$39.7M$68.7M$110.5M$118.9M$92.9M$74.6M$63.1M
Pre-tax income $216.4M-$101.3M-$48.4M$81.4M$135.2M$7.1M$58.8M$166.2M$385.7M$513.8M
Income tax $51.0M$2.3M$12.0M$18.8M$27.2M$16.7M$16.6M$44.7M$80.2M$189.2M
Net income $165.4M-$99.1M-$60.4M$66.3M$131.0M-$796.5M-$1.50B$268.6M$320.4M$324.9M
EPS, basic 1.97-1.19-0.730.791.54-9.55-17.942.953.473.52
EPS, diluted 1.94-1.19-0.730.791.53-9.55-17.832.933.453.49
Shares, diluted (wtd. avg.) $85.3M$83.3M$82.2M$84.1M$85.8M$83.4M$84.0M$91.6M$93.0M$93.1M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $375.2M$229.9M$73.3M$9.8M$387.4M$1.12B$107.9M$40.8M$40.4M$55.7M
Short-term investments $124.5M$118.6M$104.5M$93.2M$99.7M$104.9M$74.5M$21.9M
Receivables $229.7M$260.0M$272.3M$296.8M$301.8M$241.9M$434.3M$506.7M$504.0M$495.3M
Total current assets $763.5M$639.6M$483.5M$428.0M$840.6M$1.55B$731.5M$660.0M$627.2M$587.1M
Property, plant and equipment $39.2M$39.2M$75.6M$73.3M$70.2M$76.2M$72.7M$90.4M$123.5M$103.1M
Goodwill $1.26B$1.24B$1.38B$1.53B$1.51B$1.48B$1.48B$4.06B$4.28B$3.85B
Other intangibles $16.9M$11.6M$21.2M$18.5M$21.6M$26.6M$28.6M$313.2M$639.9M$668.5M
Total assets $2.25B$2.15B$2.22B$2.35B$2.72B$3.35B$4.15B$5.94B$5.87B$5.34B
Accounts payable $37.2M$46.4M$34.6M$31.9M$36.6M$59.8M$35.4M$31.1M$34.6M$28.5M
Short-term debt $20.0M
Total current liabilities $458.9M$434.1M$388.9M$427.0M$427.4M$444.3M$541.8M$502.8M$531.4M$448.9M
Long-term debt $611.2M$622.2M$637.2M$989.7M$1.70B$1.70B$1.97B$1.85B$1.68B
Total liabilities $1.38B$1.39B$1.37B$1.46B$1.83B$2.60B$2.65B$2.85B$2.80B$2.58B
Retained earnings -$83.2M-$248.5M-$149.5M-$89.1M-$155.4M-$286.4M$510.1M$2.09B$2.05B$1.79B
Total equity $865.9M$764.9M$849.1M$891.6M$896.7M$747.7M$1.50B$3.09B$3.07B$2.76B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $271.1M$206.6M$137.3M$166.9M$76.7M$204.6M$357.7M$313.7M$511.4M$443.8M
Depreciation and amortisation $21.8M$32.2M$36.2M$35.6M$32.1M$28.4M$25.9M$24.4M$78.9M$89.3M
Stock-based compensation $18.0M$11.9M$12.3M$16.1M$19.0M$39.0M$33.4M$36.6M$28.8M$34.0M
Investing cash flow -$18.3M-$35.4M-$48.2M-$57.0M-$53.1M$815.5M$102.5M-$142.8M-$576.6M-$821.2M
Financing cash flow -$107.5M-$14.5M-$25.7M-$487.6M-$760.1M-$4.2M-$393.1M-$170.6M$89.7M$381.6M
Buybacks $86.7M$1.7M$919.0K$88.5M$4.7M$8.5M$145.3M$302.2M$70.2M$61.8M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-058074.

Others in SIC 8060

TickerCompanyMarket capP/ERevenue growth
EHC Encompass Health Corp $12.01B 22.0x 10.5%